BackAcura Pharmaceuticals Overview

Acura Pharmaceuticals Current Cash

Track Acura Pharmaceuticals's current cash ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$0.00

Peer average

Loading

Acura Pharmaceuticals Current Cash History

Loading

Acura Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Acura Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Acura Pharmaceuticals (ACUR) FAQ

The latest current cash for ACUR is $0 as of September 2023. In the prior-year period, the figure was $0. Investors often review this figure alongside Acura Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACUR's current cash moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Acura Pharmaceuticals's operating scale or balance-sheet position.

A current cash figure of $0 for ACUR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ACUR's current cash ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.